FLDM Fluidigm Corp

Fluidigm Corp creates, manufactures, and markets technologies and life-science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon microfluidics and mass cytometry technologies.

$4.61  -0.11 (-2.23%)
As of 04/09/2021 15:59:50 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  02/10/2011
Outstanding shares:  74,546,957
Average volume:  1,130,394
Market cap:   $342,916,002
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    34385P108
ISIN:        US34385P1084
Sedol:      B3D32T9
Valuation   (See tab for details)
PE ratio:   -6.47
PB ratio:   2.47
PS ratio:   2.48
Return on equity:   -38.13%
Net income %:   -38.38%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy